Upgrade to SI Premium - Free Trial

Truist Securities Starts Alkermes (ALKS) at Buy

October 16, 2026 5:18 AM

Truist Securities analyst Danielle Brill initiates coverage on Alkermes (NASDAQ: ALKS) with a Buy rating and a price target of $55.00.


For an analyst ratings summary and ratings history on Alkermes click here. For more ratings news on Alkermes click here.


Shares of Alkermes closed at $40.10 yesterday.

Categories

New Coverage